Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Vir Biotechnology, Inc. (VIR)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-05-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Dec-05-21 |
| | 10-Q | 10-Q | 8-K | 10-Q | 10-Q | 10-Q | 10-K | 8-K |
| Revenues | | 100.0% | | 100.0% | 100.0% | 100.0% | 100.0% | |
| Cost of goods sold | | 116.3% | | 43.9% | 48.5% | 29.1% | 101.2% | |
| Gross profit | | -16.3% | | 56.1% | 51.5% | 70.9% | -1.2% | |
| Selling, general and administrative | | 18.0% | | 20.0% | 22.5% | 2.4% | 39.6% | |
| Research and development | | | | | 5.5% | | | |
| General and administrative | | 0.0% | | 0.0% | | 0.0% | | |
| EBITDA | | -60.4% | | 57.6% | 66.7% | 75.0% | 62.5% | |
| Depreciation | | 1.9% | | 0.2% | 0.3% | 0.2% | 0.5% | |
| EBITA | | -62.3% | | 57.4% | 66.4% | 74.8% | 62.0% | |
| Amortization of intangibles | | | | | 0.0% | | | |
| EBIT | | -62.3% | | 57.4% | 66.4% | 74.8% | 62.0% | |
| Pre-tax income | | -69.6% | | 61.0% | 63.8% | 70.5% | 50.2% | |
| Income taxes | | -37.4% | | 13.0% | 12.7% | 18.2% | 1.9% | |
| Net income | | -32.2% | | 48.0% | 51.1% | 52.3% | 48.3% | |
|